Hottub News

Lilly's Retatrutide Drives Significant Weight Loss And A1C Improvement In Phase 3 Diabetes Study

2 reports from 2 outlets in 1 language · first reported · updated · JSON

HealthLillyretatrutideobesitytype 2 diabetes

Reports

  1. Lilly's Retatrutide Drives Significant Weight Loss And A1C Improvement In Phase 3 Diabetes Studyrttnews.com · en ·
  2. Lilly's triple agonist, retatrutide, delivered substantial weight loss and A1C reduction, underscoring its potential promise for people with obesity and type 2 diabetesprnewswire.com · en ·

More in Health

  1. Democratic Republic of Congo: More than 4,000 people in the DR Congo have died from Ebola104 outlets
  2. Doctors warn about the risks energy drinks pose to kids. What families need to know68 outlets
  3. More than 4000 Ebola deaths in Democratic Republic of Congo65 outlets
  4. Life expectancy almost back to pre-Covid levels, says WHO47 outlets
  5. Former Eljamel patient’s ‘shock’ at health board’s approach to inquiry131 outlets
  6. Alison Hammond provides health update after clutching chest on live television35 outlets